Medtronic plc Stock News

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be

Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.

Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.

The medical device maker's growth rate has averaged less than 2% in the past five years. However, it's still innovating and recently launched an AI-assisted endoscopy system.

Although dividend investing has plenty of research backing its efficacy, it's a slow burn. Further, it may incur high opportunity costs during broad-market rallies, such as what we saw during the bull

AI could solve one of the biggest problems in drug development: the lengthy time it takes to bring a product to market. The AI in healthcare market is set to expand at a compound annual growth rate of

Medtronic is a healthcare technology company that has seen encouraging growth in the current fiscal year. The company has maintained pricing power and has a strong balance sheet, with an A+ grade for

Medtronic is undervalued compared to its long-term P/E ratio and has potential for strong returns. The company's focus on innovation and product diversification positions it well for future growth.

Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.

Dividend stocks are finally cycling back into portfolios after a few years' worth of higher interest rates put fixed-income options ahead of dividend distribution yield for income investors. As those

Medtronic (MDT) reachead $82.33 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.

A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.

In the closing of the recent trading day, Medtronic (MDT) stood at $83.92, denoting a -1.27% change from the preceding trading day.